The rising interest in GLP-1 medications for diabetes has led to a debate about delivery methods : transdermal systems versus tablets . Typically, GLP-1 therapies were exclusively available in oral https://louisetekr919040.mpeblog.com/73926860/glp-1-transdermal-delivery-systems-vs-oral-medications-is-suitable-for-the-patient